Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

FDA approves Ofev® as the first and only therapy to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated ILD
FDA approves Ofev® as the first and only therapy to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated ILD
RIDGEFIELD, Conn.
‘Unsafe’ levels of antibiotics found in rivers in 72 countries
‘Unsafe’ levels of antibiotics found in rivers in 72 countries
Rivers worldwide are polluted with antibiotics that exceed environmental safety thresholds by up to 300 times, according to research unveiled at a conference Monday.
Takeda recalls eye drug Natpara but warns patients not to abruptly stop treatment
Takeda recalls eye drug Natpara but warns patients not to abruptly stop treatment
Takeda Pharmaceutical’s been looking for a buyer for Natpara to provide some debt relief, but it has just run into some complicating circumstances.
Vertex spends nearly $1bn on Semma's unproven diabetes cell tech
Vertex spends nearly $1bn on Semma's unproven diabetes cell tech
It is now up to Vertex to make a success of the group’s technology, which involves using a device to allow the implantation of pancreatic islet cells in the hope of curing type 1 diabetes.
Trump Administration Announces $1.8 Billion in Funding to States to Continue Combating Opioid Crisis
Trump Administration Announces $1.8 Billion in Funding to States to Continue Combating Opioid Crisis
Today, the U.
Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report
Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report
In the 1980s, only 4% of new drugs approved by the FDA were cancer treatments.
UTA scientist explores using nanoparticles to reduce size of deep-seated tumors
UTA scientist explores using nanoparticles to reduce size of deep-seated tumors
Another collaborative project from a nanoparticles expert at The University of Texas at Arlington has yielded promising results in the search for more effective, targeted cancer treatments.
Tuberculosis mutation discovery paves way for better treatments
Tuberculosis mutation discovery paves way for better treatments
PNAS publishes Rutgers New Jersey Medical school study.
Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease
Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease
SOUTH SAN FRANCISCO, Calif.
Israeli researchers develop antibacterial coating for implants to prevent infections
Israeli researchers develop antibacterial coating for implants to prevent infections
JERUSALEM, Sept.
FDA Singles Out 9 More Drug Substances Not for Compounding
FDA Singles Out 9 More Drug Substances Not for Compounding
FDA Singles Out 9 More Drug Substances Not for CompoundingFollowing a court win late last month to keep one such drug substance out of the hands of compounders, the US Food and Drug Administration ...
Allergan : Receives FDA Approval of Juvederm VOLUMA XC for Mid-Face Injection via Cannula
Allergan : Receives FDA Approval of Juvederm VOLUMA XC for Mid-Face Injection via Cannula
DUBLIN - Allergan plc (NYSE.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand